Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)
Ratios

Tango Therapeutics (TNGX) Leases (2020 - 2025)

Tango Therapeutics has reported Leases over the past 6 years, most recently at $35.6 million for Q4 2025.

  • Quarterly results put Leases at $35.6 million for Q4 2025, down 9.81% from a year ago — trailing twelve months through Dec 2025 was $35.6 million (down 9.81% YoY), and the annual figure for FY2025 was $35.6 million, down 9.81%.
  • Leases for Q4 2025 was $35.6 million at Tango Therapeutics, down from $36.6 million in the prior quarter.
  • Over the last five years, Leases for TNGX hit a ceiling of $47.8 million in Q3 2022 and a floor of $520000.0 in Q2 2022.
  • Median Leases over the past 5 years was $40.1 million (2024), compared with a mean of $33.1 million.
  • Biggest five-year swings in Leases: plummeted 83.24% in 2021 and later soared 8616.35% in 2023.
  • Tango Therapeutics' Leases stood at $1.3 million in 2021, then skyrocketed by 3640.03% to $46.9 million in 2022, then fell by 7.23% to $43.5 million in 2023, then decreased by 9.21% to $39.5 million in 2024, then dropped by 9.81% to $35.6 million in 2025.
  • The last three reported values for Leases were $35.6 million (Q4 2025), $36.6 million (Q3 2025), and $37.6 million (Q2 2025) per Business Quant data.